A brief overview of screening recommendations, treatment advances, and the role of the navigator in managing care of patients with GI cancers.
Use of nurse navigators improved the referral process for patients with GI-related malignancies and significantly reduced the time from referral to treatment.
An overview of safe handling concerns regarding handling and administration of a recently approved receptor-binding radionuclide.
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity.
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival.